IVERIC bio, Inc. (ISEE): Price and Financial Metrics

IVERIC bio, Inc. (ISEE): $38.90

0.20 (+0.52%)

POWR Rating

Component Grades








Add ISEE to Watchlist
Sign Up

Industry: Biotech




#353 of 381

in industry

ISEE Price/Volume Stats

Current price $38.90 52-week high $38.99
Prev. close $38.70 52-week low $8.85
Day low $38.70 Volume 3,378,800
Day high $38.99 Avg. volume 3,200,555
50-day MA $33.02 Dividend yield N/A
200-day MA $23.36 Market Cap 5.36B

ISEE Stock Price Chart Interactive Chart >

IVERIC bio, Inc. (ISEE) Company Bio

IVERIC bio, Inc. (formerly Ophthotech Corporation) is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). The company was founded in 2007 and is based in New York, New York.

ISEE Latest News Stream

Event/Time News Detail
Loading, please wait...

ISEE Latest Social Stream

Loading social stream, please wait...

View Full ISEE Social Stream

Latest ISEE News From Around the Web

Below are the latest news stories about IVERIC BIO INC that investors may wish to consider to help them evaluate ISEE as an investment opportunity.

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PARSIPPANY, N.J., June 02, 2023--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to three newly-hired, non-executive employees.

Yahoo | June 2, 2023

Annexon (ANNX) Stock Down More Than 50% Last Week: Here's Why

Annexon (ANNX) announces mixed top-line results from the phase II study of ANX007 in patients with geographic atrophy.

Yahoo | May 30, 2023

Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma

Astellas Pharma snapped up Iveric Bio for $5.9 billion in cash, the companies said Monday in an announcement that sent ISEE stock flying.

Yahoo | May 1, 2023

These Stocks Moved the Most Today: First Republic, JPMorgan, Iveric Bio, SoFi, Norwegian Cruise, ON Semi, and More

JPMorgan Chase is acquiring all the deposits and 'substantially all of the assets' of regional lender First Republic Bank. Iveric Bio is being bought by Japan's Astellas Pharma for $5.9 billion.

Yahoo | May 1, 2023

First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories

Benzinga First Republic Folds As Banking Crisis Claims Third Victim: JPMorgan To Buy Deposits, Assets The First Republic Bank (NYSE: FRC) saga is winding to a close, with the Federal Deposit Insurance Corporation confirming the shuttering of the bank and the sale of its assets to JPMorgan Chase & Co. (NYSE: JPM). The California Department of Financial Protection and Innovation closed San Francisco-based First Republic on Monday. The FDIC was appointed receiver, a statement released by the federa

Yahoo | May 1, 2023

Read More 'ISEE' Stories Here

ISEE Price Returns

1-mo 3.21%
3-mo 70.76%
6-mo 92.10%
1-year 254.28%
3-year 855.77%
5-year 1,188.08%
YTD 81.69%
2022 28.05%
2021 141.97%
2020 -19.46%
2019 615.00%
2018 -61.54%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!